Researchers at UC San Francisco (UCSF) have developed a novel, potentially life-saving approach that may prevent antibodies from triggering immune rejection of engineered therapeutic and transplant cells. Rejection mediated by antibodies-as opposed to the chemical assault initiated by immune cells-has proven particularly tricky to resolve, a factor holding back the development of some of these
Read More
